Why RNA? Atrium Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
RNA
$13.43+0.66 (+5.17%)
Market ClosedLast close May 1
Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies.